Compile Data Set for Download or QSAR
Report error Found 21 Enz. Inhib. hit(s) with all data for entry = 5931
TargetEpidermal growth factor receptor(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 101239BDBM101239(US8524722, 119)
Affinity DataIC50: 1nMpH: 7.0 T: 2°CAssay Description:EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2013
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 101237BDBM101237(US8524722, 90)
Affinity DataIC50: 1nMpH: 7.0 T: 2°CAssay Description:EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2013
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 101228BDBM101228(US8524722, 12)
Affinity DataIC50: 1nMpH: 7.0 T: 2°CAssay Description:EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2013
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 101243BDBM101243(US8524722, 143)
Affinity DataIC50: 1nMpH: 7.0 T: 2°CAssay Description:EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2013
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 101226BDBM101226(US8524722, 5)
Affinity DataIC50: 1nMpH: 7.0 T: 2°CAssay Description:EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2013
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 101241BDBM101241(US8524722, 134)
Affinity DataIC50: 1nMpH: 7.0 T: 2°CAssay Description:EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2013
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 101240BDBM101240(US8524722, 123)
Affinity DataIC50: 1nMpH: 7.0 T: 2°CAssay Description:EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2013
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 101231BDBM101231(US8524722, 31)
Affinity DataIC50: 1nMpH: 7.0 T: 2°CAssay Description:EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2013
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 101230BDBM101230(US8524722, 14)
Affinity DataIC50: 1nMpH: 7.0 T: 2°CAssay Description:EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2013
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 101232BDBM101232(US8524722, 70)
Affinity DataIC50: 1nMpH: 7.0 T: 2°CAssay Description:EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2013
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 101227BDBM101227(US8524722, 10)
Affinity DataIC50: 1.10nMpH: 7.0 T: 2°CAssay Description:EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2013
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 101234BDBM101234(US8524722, 84)
Affinity DataIC50: 1.40nMpH: 7.0 T: 2°CAssay Description:EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2013
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 101229BDBM101229(US8524722, 13)
Affinity DataIC50: 2nMpH: 7.0 T: 2°CAssay Description:EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2013
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 101244BDBM101244(US8524722, 148)
Affinity DataIC50: 4.30nMpH: 7.0 T: 2°CAssay Description:EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2013
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 50330241BDBM50330241(CHEMBL1271561 | US8524722, 23 | (E)-4-(Dimethylami...)
Affinity DataIC50: 4.60nMpH: 7.0 T: 2°CAssay Description:EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2013
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 101235BDBM101235(US8524722, 86)
Affinity DataIC50: 5nMpH: 7.0 T: 2°CAssay Description:EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2013
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 101245BDBM101245(US8524722, 151)
Affinity DataIC50: 6.40nMpH: 7.0 T: 2°CAssay Description:EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2013
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 101242BDBM101242(US8524722, 139)
Affinity DataIC50: 9.20nMpH: 7.0 T: 2°CAssay Description:EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2013
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 101238BDBM101238(US8524722, 95)
Affinity DataIC50: 10nMpH: 7.0 T: 2°CAssay Description:EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2013
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 101233BDBM101233(US8524722, 81)
Affinity DataIC50: 12nMpH: 7.0 T: 2°CAssay Description:EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2013
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 101236BDBM101236(US8524722, 87)
Affinity DataIC50: 19nMpH: 7.0 T: 2°CAssay Description:EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2013
Entry Details
US Patent